Nelson, Van Denburg & Campbell Wealth Management Group, LLC Pfizer Inc Transaction History

Nelson, Van Denburg & Campbell Wealth Management Group, LLC

$2.42 Billion
Q3 2024

A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 52,177 shares of PFE stock, worth $1.43 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

52,177

Previous 51,379 1.55%

Holding current value

$1.43 Million

Previous $1.44 Million 5.08%

% of portfolio

0.06%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$27.7 - $31.39 $22,104 - $25,049	798 Added 1.55%	52,177 $1.51 Million
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $113,619 - $133,140	-4,498 Reduced 8.05%	51,379 $1.44 Million
Q1 2024 Apr 30, 2024	BUY	$25.89 - $29.73 $403,702 - $463,579	15,593 Added 38.71%	55,877 $1.55 Million
Q4 2023 Jan 30, 2024	SELL	$26.13 - $33.94 $53,749 - $69,814	-2,057 Reduced 4.86%	40,284 $1.16 Million
Q3 2023 Oct 17, 2023	BUY	$32.09 - $37.51 $108,047 - $126,296	3,367 Added 8.64%	42,341 $1.4 Million
Q2 2023 Jul 19, 2023	SELL	$36.12 - $41.79 $109,082 - $126,205	-3,020 Reduced 7.19%	38,974 $1.43 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $385,076 - $501,313	9,776 Added 30.34%	41,994 $1.71 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $136,230 - $177,833	-3,263 Reduced 9.2%	32,218 $1.65 Million
Q3 2022 Oct 26, 2022	BUY	$43.76 - $53.42 $48,529 - $59,242	1,109 Added 3.23%	35,481 $1.55 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $6,235 - $7,392	-134 Reduced 0.39%	34,372 $1.8 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $34,998 - $43,367	765 Added 2.27%	34,506 $1.79 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $77,764 - $115,272	1,882 Added 5.91%	33,741 $1.99 Million
Q3 2021 Nov 02, 2021	SELL	$39.25 - $50.42 $17,584 - $22,588	-448 Reduced 1.39%	31,859 $1.37 Million
Q2 2021 Jul 27, 2021	BUY	$35.91 - $40.68 $6,499 - $7,363	181 Added 0.56%	32,307 $1.27 Million
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $1 Million - $1.13 Million	-29,964 Reduced 48.26%	32,126 $1.16 Million
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $204,669 - $260,254	6,115 Added 10.92%	62,090 $2.29 Million
Q3 2020 Oct 20, 2020	BUY	$31.75 - $37.25 $142,621 - $167,327	4,492 Added 8.73%	55,975 $2.05 Million
Q2 2020 Jul 02, 2020	BUY	$30.12 - $36.54 $9,548 - $11,583	317 Added 0.62%	51,483 $1.6 Million
Q1 2020 Apr 01, 2020	SELL	$27.03 - $38.62 $20,029 - $28,617	-741 Reduced 1.43%	51,166 $1.58 Million
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $46,581 - $52,864	1,415 Added 2.8%	51,907 $1.93 Million
Q3 2019 Oct 09, 2019	SELL	$32.49 - $42.13 $465,549 - $603,680	-14,329 Reduced 22.11%	50,492 $1.72 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $211,784 - $237,785	5,727 Added 9.69%	64,821 $2.81 Million
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $26,025 - $28,592	694 Added 1.19%	59,094 $2.49 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $13,849 - $15,789	-360 Reduced 0.61%	58,400 $2.52 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $7,514 - $9,114	-218 Reduced 0.37%	58,760 $2.56 Million
Q2 2018 Aug 16, 2018	SELL	$32.98 - $35.16 $102,435 - $109,206	-3,106 Reduced 5.0%	58,978 $2.14 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $43,525 - $50,495	-1,364 Reduced 2.15%	62,084 $2.2 Million
Q4 2017 Feb 08, 2018	BUY	$33.26 - $35.29 $603,170 - $639,984	18,135 Added 40.02%	63,448 $2.3 Million
Q3 2017 Nov 08, 2017	SELL	$31.0 - $34.15 $247,349 - $272,482	-7,979 Reduced 14.97%	45,313 $1.94 Million
Q2 2017 Aug 15, 2017	BUY	N/A	53,292	53,292 $1.79 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.

Account

Nelson, Van Denburg & Campbell Wealth Management Group, LLC Pfizer Inc Transaction History